zntl: the cashflow

MyFinsight

For the quarter ending 2025-09-30.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Cash Flow	2025-09-30	2025-06-30
Net cash provided by financing activities	304	189
Net increase in cash, cash equivalents and restricted cash	5,171	3,698
Cash and cash equivalents at beginning of period	36,528	-
Cash and cash equivalents at end of period	41,699	-

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

For the quarter ending 2025-09-30.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Cash Flow	2025-09-30	2025-06-30
Net cash provided by financing activities	304	189
Net increase in cash, cash equivalents and restricted cash	5,171	3,698
Cash and cash equivalents at beginning of period	36,528	-
Cash and cash equivalents at end of period	41,699	-

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Zentalis Pharmaceuticals, Inc. (ZNTL)